Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Max Drawdown (5Y): 93.03% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 93.03% |
March 31, 2024 | 86.69% |
February 29, 2024 | 85.43% |
January 31, 2024 | 85.43% |
December 31, 2023 | 85.43% |
November 30, 2023 | 85.43% |
October 31, 2023 | 85.43% |
September 30, 2023 | 84.42% |
August 31, 2023 | 84.42% |
July 31, 2023 | 84.42% |
June 30, 2023 | 84.42% |
May 31, 2023 | 84.42% |
April 30, 2023 | 84.42% |
March 31, 2023 | 84.42% |
February 28, 2023 | 84.42% |
January 31, 2023 | 84.42% |
December 31, 2022 | 84.42% |
November 30, 2022 | 84.42% |
October 31, 2022 | 84.42% |
September 30, 2022 | 84.42% |
August 31, 2022 | 84.42% |
July 31, 2022 | 83.12% |
June 30, 2022 | 82.81% |
May 31, 2022 | 82.21% |
April 30, 2022 | 82.21% |
Date | Value |
---|---|
March 31, 2022 | 82.21% |
February 28, 2022 | 82.21% |
January 31, 2022 | 82.21% |
December 31, 2021 | 82.21% |
November 30, 2021 | 82.21% |
October 31, 2021 | 82.21% |
September 30, 2021 | 82.21% |
August 31, 2021 | 82.21% |
July 31, 2021 | 82.21% |
June 30, 2021 | 82.21% |
May 31, 2021 | 82.21% |
April 30, 2021 | 82.21% |
March 31, 2021 | 82.21% |
February 28, 2021 | 82.21% |
January 31, 2021 | 82.21% |
December 31, 2020 | 82.21% |
November 30, 2020 | 82.21% |
October 31, 2020 | 82.21% |
September 30, 2020 | 82.21% |
August 31, 2020 | 82.21% |
July 31, 2020 | 82.21% |
June 30, 2020 | 82.21% |
May 31, 2020 | 82.21% |
April 30, 2020 | 82.21% |
March 31, 2020 | 82.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.87%
Minimum
May 2019
93.03%
Maximum
Apr 2024
81.95%
Average
82.21%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Alpine Immune Sciences Inc | 97.33% |
Lantern Pharma Inc | -- |
Oragenics Inc | 98.92% |
MAIA Biotechnology Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -54.21 |
Beta (5Y) | 1.709 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.44% |
Historical Sharpe Ratio (5Y) | -0.4164 |
Historical Sortino (5Y) | -0.7862 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.79% |